Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Sundrug Co.,Ltd.
  6. Summary
    9989   JP3336600006

SUNDRUG CO.,LTD.

(9989)
  Report
Delayed Japan Exchange  -  01:00:00 2023-02-03 am EST
3605.00 JPY   -1.64%
2022SUNDRUG CO.,LTD. : Ex-dividend day for interim dividend
FA
2022Sundrug Co.,Ltd. agreed to acquire Daiya, K.K. from Shintaro Ito, Ichiban Co., Ltd and others.
CI
2022Foreigners net buyers in Japanese stocks for a third consecutive week
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
01/30/2023 01/31/2023 02/01/2023 02/02/2023 02/03/2023 Date
3650(c) 3675(c) 3685(c) 3665(c) 3605(c) Last
309 700 262 800 253 300 248 800 294 800 Volume
+0.69% +0.68% +0.27% -0.54% -1.64% Change
More quotes
Estimated financial data (e)
Sales 2023 695 B 5 306 M 5 306 M
Net income 2023 24 814 M 190 M 190 M
Net cash position 2023 85 840 M 656 M 656 M
P/E ratio 2023 17,0x
Yield 2023 2,69%
Sales 2024 749 B 5 722 M 5 722 M
Net income 2024 26 686 M 204 M 204 M
Net cash position 2024 84 655 M 647 M 647 M
P/E ratio 2024 15,8x
Yield 2024 2,87%
Capitalization 422 B 3 219 M 3 219 M
EV / Sales 2023 0,48x
EV / Sales 2024 0,45x
Nbr of Employees 6 015
Free-Float 56,6%
More Financials
Company
SUNDRUG CO., LTD. is a Japan-based company operating in two business segments. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others. 
Sector
Drug Retailers
Calendar
02/14Earnings Release
More about the company
Ratings of Sundrug Co.,Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D-
More Ratings
All news about SUNDRUG CO.,LTD.
2022SUNDRUG CO.,LTD. : Ex-dividend day for interim dividend
FA
2022Sundrug Co.,Ltd. agreed to acquire Daiya, K.K. from Shintaro Ito, Ichiban Co., Ltd and ..
CI
2022Foreigners net buyers in Japanese stocks for a third consecutive week
RE
2022Nikkei hits over 7-month high on Wall Street optimism, robust earnings
RE
2022Japanese shares rise on Wall Street optimism, strong earnings
RE
2022SUNDRUG CO.,LTD. : Ex-dividend day for final dividend
FA
2022Sundrug Co.,Ltd. agreed to acquire Skinvill from I-ne CO., LTD..
CI
2021SUNDRUG CO.,LTD. : Ex-dividend day for interim dividend
FA
2021SUNDRUG CO.,LTD. : Ex-dividend day for final dividend
FA
2020SUNDRUG CO.,LTD. : Ex-dividend day for interim dividend
FA
2020SUNDRUG CO.,LTD. : Ex-dividend day for final dividend
FA
2019SUNDRUG CO LTD : Ex-dividend day for interim dividend
FA
2019SUNDRUG CO LTD : Ex-dividend day for final dividend
FA
2018SUNDRUG CO LTD : Ex-dividend day for interim dividend
FA
2018SUNDRUG CO LTD : Ex-dividend day for final dividend
FA
More news
News in other languages on SUNDRUG CO.,LTD.
2022Les étrangers sont les acheteurs nets des actions japonaises pour la troisième semaine ..
2022Les actions japonaises augmentent grâce à l'optimisme de Wall street et à de bons résul..
More news
ETFs positioned on SUNDRUG CO.,LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Nomura NEXT FUNDS TOPIX-17 RETAIL TRADE ETF - JPY1.15%-0.74%-Japan
Nomura Russell/Nomura Small Cap Core Index ...0.47%0.50%-Japan
Mackenzie Maximum Diversification All World...0.25%-0.41%World
IShares MSCI Japan Small-Cap ETF - USD0.24%-1.61%Japan
Invesco FTSE RAFI Developed Markets ex-U.S....0.14%-0.63%World
More ETFs positioned on SUNDRUG CO.,LTD.
Chart SUNDRUG CO.,LTD.
Duration : Period :
Sundrug Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUNDRUG CO.,LTD.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 3 605,00 JPY
Average target price 4 028,57 JPY
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Hiroshi Sadakata Executive Officer & Manager-Sales II
Tatsuro Saitsu Director & Manager-Sales
Yoshinobu Kato Manager-Administration
Naoki Tada Director & General Manager-Administration
Nobuhiko Sugiura Independent Outside Director
Sector and Competitors